BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3497914)

  • 1. The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamases.
    Ashby J; Kirkpatrick B; Piddock LJ; Wise R
    J Antimicrob Chemother; 1987 Jul; 20(1):15-22. PubMed ID: 3497914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
    Gootz TD; Sanders CC; Goering RV
    J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics.
    Tejedor-Junco MT; González-Martín M; Lupiola P; González-Lama Z
    Folia Microbiol (Praha); 1998; 43(6):683-6. PubMed ID: 10069013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of imipenem on Enterobacter cloacae].
    Donnio PY; Lebert P; Travert MF; Avril JL
    Pathol Biol (Paris); 1988 May; 36(5):456-9. PubMed ID: 3043343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.
    Stapleton P; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Sep; 36(3):483-96. PubMed ID: 8830012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae.
    Yang YJ; Livermore DM; Williams RJ
    J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extended-spectrum beta-lactamase detection in Enterobacteriaceae and antibiotic susceptibility analysis].
    Cao W; Tong MH; Wang JG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):77-8. PubMed ID: 12575246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of temocillin and other penicillins against beta-lactamase-inducible and -stably derepressed enterobacteria.
    Yang Y; Livermore DM
    J Antimicrob Chemother; 1988 Sep; 22(3):299-306. PubMed ID: 3263354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    Livermore DM; Yang YJ
    J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Eley A; Greenwood D
    J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain.
    Colom K; Fernández-Aranguiz A; Alonso R; Suinaga E; Cisterna R
    Microb Drug Resist; 1996; 2(3):353-9. PubMed ID: 9158795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
    Andrew JH; Greenwood D
    J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of biapenem against beta-lactamase producing Enterobacteriaceae.
    Alonso R; Fernández-Aranguiz A; Colom K; Morla A; Suinaga E; Umaran A; Cisterna R
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):820-2. PubMed ID: 7889951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.